UMC IDMP Request and Publish API, published by Uppsala Monitoring Centre. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Uppsala-Monitoring-Centre/WHO-UMC-IDMP-Service/ and changes regularly. See the Directory of published versions
Profile: http://umcterminologies.org/StructureDefinition/AdministrableProductDefinition-pub
Pharmaceutical dose form - BasicDoseForm: standardterms.edqm.eu: 0069 (Tablet)
Pharmaceutical dose form - ReleaseCharacteristics: standardterms.edqm.eu: 0047 (Conventional)
Pharmaceutical dose form - AdministrationMethod: standardterms.edqm.eu: 0019 (Swallowing)
Pharmaceutical dose form - IntendedSite: standardterms.edqm.eu: 0031 (Oral)
Parent PhPID: AdministrableProductDefinition: identifier = Level 1; status = active
identifier: Level 4/UTPHPID102Y0G2TFV6GU6
status: Active
| Code |
Generated Narrative: Ingredient #3dcd3350-417a-47a8-a17f-79dfb36b4c3a
Profile:
http://umcterminologies.org/StructureDefinition/Ingredient-phpid-pubstatus: Active
role: Active
substance
Codes
Reference Nilotinib tartrate strength
presentation: 121.93 mg (Details: UCUM codemg = 'mg')
textPresentation: 121.93 mg
referenceStrength
Substances
Reference Nilotinib strength: 95 mg (Details: UCUM codemg = 'mg')